35 results about "Hepatorenal failure" patented technology

The present invention is to provide an agent for preventing and / or treating multiple organ failure comprising Tumor cytotoxic factor-II (TCF-II) or Hepatocyte growth factor (HGF) as an effective ingredient. The agent of the present invention will be useful for preventing and / or treating the development from burn, disseminated intravascular coagulation (DIC), circulatory failure, hemorrhagic shock, infectious disease, acute pancreatitis, ischemic disorder, hepatorenal syndrome, gastrointestinal hemorrhage, nutritional metabolic failure, terminal cancer, acquired immunodeficiency syndrome (AIDS), deterioration of systemic conditions due to radiation affection and cachexia etc. to multiple organ failure.

The invention relates to the technical field of a pure traditional Chinese medicine, in particular to a medicine for treating ascites due to cirrhosis and hepatorenal syndrome, and a preparation method thereof. The medicine overcomes different defects respectively existing in medicines and methods for treating kidney diseases and uremia. The medicine of the invention is prepared by musk, red ginseng, barley, cornu saigae tataricae, radix asparagi, tuber pinellia, Chinese yam, tuckahoe, liquorice, ballonflower and honeysuckle. The preparation method comprises the following steps: the medicinesare respectively pulverized; the liquorice, the ballonflower and the honeysuckle are mixed, and water is added in the mixture; after being boiled by hard fire, the mixture is decocted by soft fire; after the mixture is placed for 24 hours, water, the weight of which is equal to that of the water added in the first time is added; then, the mixture is decocted by soft fire after being boiled by hard fire; the steps are repeated seven times according to the method; the obtained medical liquor is filtered, and other powdery medicines are added in the filter liquor; the mixture is uniformly stirred and kneaded to obtain tablets, and the tablets are dried. The medicine of the invention plays a role of treating both manifestation and root cause of disease, combining tonification and purgation, tonifying the kidney and yang, replenishing qi and blood, expelling toxin, promoting urination and protecting the kidney, and has reliable and safe curative effect. In addition, the medicine has good functions of reducing albuminuria and erythruria, metabolizing the kidney and expelling toxin.

The invention discloses a system of determining short-term prognosis of hepatic cirrhosis and hepatorenal syndrome patients. The system of determining short-term prognosis of hepatic cirrhosis and hepatorenal syndrome patients includes an input device, a computing device and an output device, wherein the computing device includes a memory and a processor; a computer program is saved in the memory;the processor is configured to execute the computer program saved in the memory so as to realize the algorithm of a discrimination function; and the discrimination function returns the short-term prognosis of hepatorenal syndrome patients to be tested through liver cancer history, creatinine (Cr), neutrophilic granulocyte percentage (NE%) and glutamic-pyruvic transaminase (ALT). The system of determining short-term prognosis of hepatic cirrhosis and hepatorenal syndrome patients performs analysis and comparison by means of the current easily obtained clinic lab test index, establishes a survival prognosis scoring model for hepatic cirrhosis and hepatorenal syndrome patients, and guides the patients to further complete the related treatment to prolong the survival time of the patients.

The invention relates to a traditional Chinese medicine for treating hepatorenal syndrome. The traditional Chinese medicine is prepared from the following medical materials in weight ratio: 12 parts of rhizoma curcumae longae, 6 parts of gynostemma pentaphylla, 8 parts of radix scrophulariae, 8 parts of apocynum venetum, 4 parts of lumbricus, 4 parts of saffron crocus, 7 parts of saussurea involucrate, 7 parts of Chinese lobelia, 7 parts of Szechuan lovage rhizome, 12 parts of radix polygonati officinalis, 12 parts of polygonum multiflorum, 6 parts of eucommia ulmoides and 8 parts of gecko. Clinical trials prove that the traditional Chinese medicine can be used for treating hepatorenal syndrome safely and effectively.

The present invention is directed to methods of treating hepatorenal syndrome by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist to a patient in need thereof. The present invention is also directed to methods of treating hepatic encephalopathy and cerebral edema by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist to a patient in need thereof.